Skip to main content
An official website of the United States government

recombinant fowlpox-CEA(6D)/TRICOM vaccine

A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the carcinoembryonic antigen (CEA) and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM). This agent may enhance CEA presentation to antigen presenting cells (APC) and activate cytotoxic T-cells against CEA-expressing tumors.
Synonym:fowlpox-CEA-B7-1/ICAM-1/LFA-3
rF-CEA(6D)TRICOM
IND number:9306
NSC code:710068
Search NCI's Drug Dictionary